Scotts Miracle-Gro
The Scotts Miracle-Gro Company manufactures, markets, and sells consumer lawn and garden products in the United States and internationally. The last earnings update was 12 days ago. More info.
Add to Portfolio Compare Print
SMG Share Price and Events
7 Day Returns
1 Year Returns
SMG Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Scotts Miracle-Gro (SMG) | 0.3% | 5.8% | 9.6% | 0.5% | 29.7% | 46.3% |
| US Chemicals | -0.6% | -7.8% | -8.9% | -15.4% | 16.9% | 6.7% |
| US Market | -0.7% | -2% | 2.4% | 3% | 39.2% | 42% |
1 Year Return vs Industry and Market
- SMG outperformed the Chemicals industry which returned -15.4% over the past year.
- SMG underperformed the Market in United States of America which returned 3% over the past year.
SMG Value
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Scotts Miracle-Gro
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Scotts Miracle-Gro.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 7 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 9.5% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Chemicals Unlevered Beta | Simply Wall St/ S&P Global | 0.87 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.87 (1 + (1- 21%) (49.32%)) |
1.14 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.14 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.14 * 5.96%) |
9.52% |
Discounted Cash Flow Calculation for NYSE:SMG using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Scotts Miracle-Gro is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 9.52%) |
|
|---|---|---|---|
| 2019 | 454.00 | Analyst x1 | 414.52 |
| 2020 | 295.00 | Analyst x2 | 245.92 |
| 2021 | 592.00 | Analyst x1 | 450.60 |
| 2022 | 714.77 | Est @ 20.74% | 496.73 |
| 2023 | 824.38 | Est @ 15.34% | 523.08 |
| 2024 | 919.63 | Est @ 11.55% | 532.77 |
| 2025 | 1,001.54 | Est @ 8.91% | 529.77 |
| 2026 | 1,072.19 | Est @ 7.05% | 517.82 |
| 2027 | 1,133.91 | Est @ 5.76% | 500.00 |
| 2028 | 1,188.89 | Est @ 4.85% | 478.66 |
| Present value of next 10 years cash flows | $4,689.87 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= $1,188.89 × (1 + 2.73%) ÷ (9.52% – 2.73%) |
$17,975.17 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $17,975.17 ÷ (1 + 9.52%)10 |
$7,236.95 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $4,689.87 + $7,236.95 |
$11,926.81 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $11,926.81 / 55.47 |
$215.01 |
| Calculation | Result | |
|---|---|---|
| Value per share (USD) | From above. | $215.01 |
| Current discount | Discount to share price of
$87.84
= -1 x ($87.84 - $215.01) / $215.01 |
59.1% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Current Discount
Current Discount Checks
- Scotts Miracle-Gro's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Scotts Miracle-Gro's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Scotts Miracle-Gro's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Scotts Miracle-Gro's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2019-03-30) in USD | $5.58 |
| NYSE:SMG Share Price ** | NYSE (2019-05-17) in USD | $87.84 |
| United States of America Chemicals Industry PE Ratio | Median Figure of 67 Publicly-Listed Chemicals Companies | 17.88x |
| United States of America Market PE Ratio | Median Figure of 3,088 Publicly-Listed Companies | 17.89x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Scotts Miracle-Gro.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NYSE:SMG Share Price ÷ EPS (both in USD) = 87.84 ÷ 5.58 |
15.73x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Scotts Miracle-Gro is good value based on earnings compared to the US Chemicals industry average.
- Scotts Miracle-Gro is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does
Scotts Miracle-Gro's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 15.73x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts |
-18%per year |
| United States of America Chemicals Industry PEG Ratio | Median Figure of 49 Publicly-Listed Chemicals Companies | 1.33x |
| United States of America Market PEG Ratio | Median Figure of 2,117 Publicly-Listed Companies | 1.56x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 15.73x ÷ -18% |
-0.87x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Scotts Miracle-Gro earnings are not expected to grow next year, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Scotts Miracle-Gro's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2019-03-30) in USD | $11.14 |
| NYSE:SMG Share Price * | NYSE (2019-05-17) in USD | $87.84 |
| United States of America Chemicals Industry PB Ratio | Median Figure of 93 Publicly-Listed Chemicals Companies | 2.09x |
| United States of America Market PB Ratio | Median Figure of 5,195 Publicly-Listed Companies | 1.83x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NYSE:SMG Share Price ÷ Book Value per Share (both in USD) = 87.84 ÷ 11.14 |
7.88x |
* Primary Listing of Scotts Miracle-Gro.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Scotts Miracle-Gro is overvalued based on assets compared to the US Chemicals industry average.
Value checks
We assess Scotts Miracle-Gro's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check) Scotts Miracle-Gro has a total score of 4/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
SMG Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Scotts Miracle-Gro's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.7%.
Growth vs Market Checks
- Scotts Miracle-Gro's earnings are expected to decrease over the next 1-3 years, this is below the United States of America market average.
- Scotts Miracle-Gro's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NYSE:SMG Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts | -18% |
| NYSE:SMG Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 7 Analysts | 2.8% |
| United States of America Chemicals Industry Earnings Growth Rate | Market Cap Weighted Average | 13.1% |
| United States of America Chemicals Industry Revenue Growth Rate | Market Cap Weighted Average | 4.3% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 13.9% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7.3% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 7 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-09-30 | 3,103 | 336 | 274 | 1 |
| 2020-09-30 | 3,065 | 376 | 261 | 7 |
| 2019-09-30 | 2,968 | 380 | 378 | 7 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2019-03-30 | 2,917 | 279 | 309 |
| 2018-12-29 | 2,740 | 320 | 65 |
| 2018-09-30 | 2,663 | 343 | 128 |
| 2018-06-30 | 2,606 | 268 | 216 |
| 2018-03-31 | 2,585 | 369 | 235 |
| 2017-12-30 | 2,656 | 363 | 236 |
| 2017-09-30 | 2,642 | 363 | 198 |
| 2017-07-01 | 2,338 | 358 | 213 |
| 2017-04-01 | 2,359 | 376 | 196 |
| 2016-12-31 | 2,519 | 366 | 268 |
| 2016-09-30 | 2,506 | 244 | 247 |
| 2016-07-02 | 2,809 | 194 | 232 |
| 2016-04-02 | 2,926 | 268 | 222 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 7 Analyst Estimates (S&P Global) | See Below |
All data from Scotts Miracle-Gro Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2021-09-30 | ||||
| 2020-09-30 | 4.78 | 5.29 | 4.31 | 3.00 |
| 2019-09-30 | 7.67 | 7.88 | 7.45 | 3.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2019-03-30 | 5.58 |
| 2018-12-29 | 1.17 |
| 2018-09-30 | 2.27 |
| 2018-06-30 | 3.79 |
| 2018-03-31 | 4.06 |
| 2017-12-30 | 4.02 |
| 2017-09-30 | 3.33 |
| 2017-07-01 | 3.56 |
| 2017-04-01 | 3.24 |
| 2016-12-31 | 4.41 |
| 2016-09-30 | 4.04 |
| 2016-07-02 | 3.79 |
| 2016-04-02 | 3.61 |
*GAAP earnings excluding extraordinary items.
Performance in 3 years
In the same way as past performance we look at the future estimated return
(profit) compared to the available
funds. We do this looking forward 3 years.
- Scotts Miracle-Gro is expected to make outstanding use of shareholders’ funds in the future (Return on Equity greater than 40%).
Future performance checks
We assess Scotts Miracle-Gro's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Scotts Miracle-Gro has a total score of 1/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
SMG Past Performance
How has Scotts Miracle-Gro performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Scotts Miracle-Gro's year on year earnings growth rate has been positive over the past 5 years.
- Scotts Miracle-Gro's 1-year earnings growth exceeds its 5-year average (31.7% vs 5%)
- Scotts Miracle-Gro's earnings growth has exceeded the US Chemicals industry average in the past year (31.7% vs 14.2%).
Earnings and Revenue History
All data from Scotts Miracle-Gro Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2019-03-30 | 2,916.50 | 309.40 | 490.50 | 42.50 |
| 2018-12-29 | 2,740.00 | 65.10 | 475.40 | 42.30 |
| 2018-09-30 | 2,663.40 | 127.60 | 468.70 | 42.50 |
| 2018-06-30 | 2,606.20 | 215.90 | 497.90 | 22.10 |
| 2018-03-31 | 2,585.00 | 234.90 | 480.40 | 39.90 |
| 2017-12-30 | 2,656.20 | 236.30 | 491.40 | 40.40 |
| 2017-09-30 | 2,642.10 | 197.80 | 489.10 | 39.90 |
| 2017-07-01 | 2,337.80 | 213.00 | 488.20 | -4.60 |
| 2017-04-01 | 2,358.50 | 195.60 | 514.70 | -20.90 |
| 2016-12-31 | 2,519.10 | 267.90 | 509.10 | -2.10 |
| 2016-09-30 | 2,506.20 | 246.60 | 468.40 | 36.00 |
| 2016-07-02 | 2,809.20 | 232.40 | 526.80 | 46.40 |
| 2016-04-02 | 2,926.40 | 221.70 | 531.60 | 45.50 |
| 2016-01-02 | 2,753.00 | 134.30 | 520.30 | 45.80 |
| 2015-09-30 | 2,371.10 | 129.80 | 488.80 | |
| 2015-06-27 | 2,806.90 | 165.30 | 547.10 | 45.40 |
| 2015-03-28 | 2,812.00 | 169.50 | 581.20 | 46.10 |
| 2014-12-27 | 2,821.20 | 156.20 | 603.80 | 47.00 |
| 2014-09-30 | 2,578.30 | 145.80 | 511.60 | 46.00 |
| 2014-06-28 | 2,820.60 | 161.40 | 623.40 | 34.30 |
| 2014-03-29 | 2,841.30 | 188.50 | 664.70 | -0.30 |
| 2013-12-28 | 2,768.20 | 162.00 | 658.50 | 0.80 |
| 2013-09-30 | 2,773.70 | 159.40 | 605.00 | 46.40 |
| 2013-06-29 | 2,741.30 | 142.00 | 668.60 | |
| 2013-03-30 | 2,659.10 | 90.60 | 650.70 | 22.40 |
| 2012-12-29 | 2,821.60 | 118.00 | 695.20 | 10.20 |
| 2012-09-30 | 2,770.50 | 111.60 | 703.30 | |
| 2012-06-30 | 2,806.10 | 96.10 | 691.50 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Whilst Scotts Miracle-Gro made outstanding use of shareholders’ funds last year (Return on Equity greater than 40%), this is metric is skewed due to its high level of debt.
- Scotts Miracle-Gro used its assets more efficiently than the US Chemicals industry average last year based on Return on Assets.
- Scotts Miracle-Gro's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Scotts Miracle-Gro's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Scotts Miracle-Gro has a total score of 4/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
SMG Health
How is Scotts Miracle-Gro's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Scotts Miracle-Gro's finances.
The net worth of a company is the difference between its assets and liabilities.
- Scotts Miracle-Gro is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Scotts Miracle-Gro's long term commitments exceed its cash and other short term assets.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is not covered by short term assets, assets are 0.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Scotts Miracle-Gro Company Filings, last reported 1 month ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2019-03-30 | 622.10 | 2,403.10 | 38.40 |
| 2018-12-29 | 253.20 | 2,286.00 | 24.40 |
| 2018-09-30 | 359.60 | 2,016.40 | 35.90 |
| 2018-06-30 | 531.30 | 2,289.90 | 31.50 |
| 2018-03-31 | 495.90 | 2,273.50 | 34.50 |
| 2017-12-30 | 507.80 | 1,784.10 | 55.90 |
| 2017-09-30 | 661.70 | 1,402.30 | 121.80 |
| 2017-07-01 | 743.00 | 1,710.40 | 120.30 |
| 2017-04-01 | 691.40 | 2,089.80 | 75.00 |
| 2016-12-31 | 592.20 | 1,722.80 | 88.80 |
| 2016-09-30 | 734.30 | 1,222.30 | 28.60 |
| 2016-07-02 | 832.20 | 1,521.50 | 77.20 |
| 2016-04-02 | 687.90 | 1,978.60 | 57.30 |
| 2016-01-02 | 526.70 | 1,542.30 | 49.00 |
| 2015-09-30 | 633.10 | 1,171.00 | 71.40 |
| 2015-06-27 | 693.40 | 1,064.30 | 79.90 |
| 2015-03-28 | 569.90 | 1,544.10 | 54.80 |
| 2014-12-27 | 460.90 | 1,185.30 | 130.10 |
| 2014-09-30 | 567.20 | 799.80 | 89.30 |
| 2014-06-28 | 755.20 | 846.20 | 147.20 |
| 2014-03-29 | 675.70 | 1,443.90 | 152.70 |
| 2013-12-28 | 621.30 | 902.40 | 124.60 |
| 2013-09-30 | 710.50 | 590.90 | 129.80 |
| 2013-06-29 | 741.80 | 728.70 | 105.40 |
| 2013-03-30 | 606.90 | 1,396.80 | 99.10 |
| 2012-12-29 | 513.80 | 1,015.30 | 115.60 |
| 2012-09-30 | 601.90 | 811.40 | 131.90 |
| 2012-06-30 | 674.00 | 796.30 | 132.30 |
- Scotts Miracle-Gro's level of debt (386.3%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has increased over the past 5 years (211.2% vs 386.3% today).
- Debt is not well covered by operating cash flow (11.6%, less than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 4.4x coverage).
Financial health checks
We assess Scotts Miracle-Gro's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Scotts Miracle-Gro has a total score of 2/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
SMG Dividends
What is Scotts Miracle-Gro's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
Scotts Miracle-Gro
shares you are expected to receive
$50
in your first year as a dividend.
Dividend Amount
- Scotts Miracle-Gro's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).
- Scotts Miracle-Gro's dividend is below the markets top 25% of dividend payers in United States of America (3.69%).
Upcoming dividend payment
Purchase Scotts Miracle-Gro before the 'Buy Limit' to receive their next dividend payment.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 7 Analyst Estimates (S&P Global) | See Below |
| United States of America Chemicals Industry Average Dividend Yield | Market Cap Weighted Average of 54 Stocks | 2.3% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2000 Stocks | 2.5% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.4% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.7% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2021-09-30 | 2.34 | 1.00 |
| 2020-09-30 | 2.34 | 3.00 |
| 2019-09-30 | 2.23 | 2.00 |
| Date (Data in $) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-04-29 | 2.200 | 2.473 |
| 2019-01-25 | 2.200 | 2.773 |
| 2018-11-07 | 2.200 | 3.211 |
| 2018-08-06 | 2.200 | 2.942 |
| 2018-04-30 | 2.120 | 2.555 |
| 2018-01-26 | 2.120 | 2.410 |
| 2017-11-01 | 2.120 | 2.068 |
| 2017-08-01 | 2.120 | 2.194 |
| 2017-05-01 | 2.000 | 2.231 |
| 2017-01-27 | 2.000 | 2.152 |
| 2016-11-10 | 2.000 | 2.155 |
| 2016-11-03 | 2.000 | 2.272 |
| 2016-08-10 | 2.000 | 2.395 |
| 2016-08-03 | 2.000 | 2.481 |
| 2016-04-29 | 1.880 | 2.681 |
| 2016-01-28 | 1.880 | 2.685 |
| 2015-10-27 | 1.880 | 2.838 |
| 2015-08-03 | 1.880 | 2.974 |
| 2015-05-01 | 1.800 | 2.934 |
| 2015-01-29 | 1.800 | 2.723 |
| 2014-10-28 | 1.800 | 2.933 |
| 2014-08-11 | 1.800 | 3.170 |
| 2014-05-02 | 1.750 | 3.048 |
| 2014-01-30 | 1.750 | 2.964 |
| 2013-10-31 | 1.750 | 2.906 |
| 2013-08-06 | 1.750 | 3.178 |
| 2013-05-10 | 1.300 | 2.664 |
| 2013-01-17 | 1.300 | 2.909 |
| 2012-11-14 | 1.300 | 3.033 |
| 2012-08-09 | 1.300 | 3.035 |
| 2012-05-03 | 1.200 | 2.874 |
| 2012-01-19 | 1.200 | 2.383 |
| 2011-11-10 | 1.200 | 2.678 |
| 2011-08-08 | 1.200 | 2.612 |
| 2011-05-05 | 1.000 | 1.906 |
| 2011-01-20 | 1.000 | 1.804 |
| 2010-11-11 | 1.000 | 1.969 |
| 2010-08-10 | 1.000 | 1.970 |
| 2010-05-12 | 0.500 | 1.096 |
| 2010-01-21 | 0.500 | 1.158 |
| 2009-11-13 | 0.500 | 1.250 |
| 2009-08-06 | 0.500 | 1.196 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Dividends per share have been stable in the past 10 years.
- Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of
Scotts Miracle-Gro's earnings are
paid
to the shareholders as a dividend.
- Dividends paid are well covered by earnings (2.6x coverage).
- Dividends after 3 years are expected to be well covered by earnings (2.1x coverage).
Income/ dividend checks
We assess Scotts Miracle-Gro's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Scotts Miracle-Gro afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Scotts Miracle-Gro has a total score of 5/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
SMG Management
CEO
| COMPENSATION | $5,156,569 |
| AGE | 63 |
| TENURE AS CEO | 18 years |
CEO Bio
Mr. James S. Hagedorn, also known as Jim, has been the Chief Executive Officer since May 2001 and has been the Chairman since January 2003 and has been its Executive Director at The Scotts Miracle-Gro Company (“Scotts Miracle”) since 1995. Mr. Hagedorn served as President at The Scotts Miracle from October 2015 to February 2016, from November 2006 until October 2008 and from April 2000 until December 2005. He served as the President of Scotts-Sierra Horticultural Products Company. He served as the Chief Executive Officer of Scotts Company (which was merged into The Scotts Company LLC in March 2005) since May 2001. He served as the President at The Scotts Miracle from November 2006 to October 1, 2008 and also from April 2000 to December 1, 2005. He served as the President and Chief Operating Officer of Scotts Company from April 2000 to May 2001 and as the President of Scotts North America, of Scotts Company from December 1998 to April 2000. Mr. Hagedorn was named Senior Vice President of Consumer Gardens Group in 1995, the year Scotts merged with Stern's Miracle-Gro Products, Inc. He served as the Executive Vice President of U.S. Business Groups at Scotts Company from October 1996 to December 1998. At Miracle-Gro, Mr. Hagedorn served as Executive Vice President and was a Major Architect of Miracle’s success both in the U.S. and in the UK. He was instrumental in the effective integration of the two businesses and served as Head of its North America business. He serves as the Chairman of the board for the Farms for City Kids Foundation, Inc. in Reading, Vt. Mr. Hagedorn also served as co-chairman of the National Fund for the U.S. Botanic Garden in Washington, D.C. He served as Chairman of Scotts Company since January 30, 2003 and served as its Executive Director since 1995. He serves as a Director for Farms For City Kids Foundation, Inc., Nurse Family Partnership, The CDC Foundation, Embry Riddle/ Aeronautical University, Northshore University Hospital (New York), Scotts Miracle Foundation and the Intrepid Sea-Air-Space Museum, all charitable organizations. He serves as a Member of the board of trustees at Embry Riddle Aeronautical University. In addition, he is Associate Trustee of the North Shore Hospital in Manhasset, N.Y.; Board Member for the Centers for Disease Control and Trustee at the Intrepid Foundation. He served in the United States Air Force for seven years, where he was a captain and an accomplished F-16 fighter pilot. Mr. Hagedorn is a graduate of The Harvard Business School Advanced Management Program and holds a degree in aeronautical science from Embry Riddle Aeronautical University.
CEO Compensation
- Jim's compensation has been consistent with company performance over the past year.
- Jim's remuneration is about average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the Scotts Miracle-Gro management team in years:
- The average tenure for the Scotts Miracle-Gro management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team
Jim Hagedorn
Chairman & CEO
$5M
63
18 yrs
Mike Lukemire
President & COO
$2M
60
3.3 yrs
Randy Coleman
Executive VP & CFO
$2M
49
5.1 yrs
Ivan Smith
Executive VP
$1M
49
5.8 yrs
Denise Stump
Executive VP of Global HR & Chief Ethics Officer
$1M
64
16.3 yrs
Jim King
Chief Communications Officer and Senior VP of Investor Relations & Corporate Affairs
Dave Swihart
Senior Vice President of Research & Development
10.9 yrs
Phil Jones
Senior Vice President of International Sales
4.3 yrs
Scott Hendrick
Senior Vice President of Global Supply Chain
8.3 yrs
Mike Hoover
Senior Vice President of Special Operating Forces
Board of Directors Tenure
Average tenure and age of the Scotts Miracle-Gro board of directors in years:
- The tenure for the Scotts Miracle-Gro board of directors is about average.
Board of Directors
Jim Hagedorn
Chairman & CEO
$5M
63
16.3 yrs
Katherine Littlefield
Vice-Chairman
$285K
63
Tom Kelly
Independent Director
$285K
70
12.8 yrs
Nancy Mistretta
Independent Director
$285K
64
11.8 yrs
Steve Johnson
Independent Director
$285K
67
8.5 yrs
Peter Shumlin
Independent Director
$285K
62
2.3 yrs
John Vines
Lead Independent Director
$335K
69
5.3 yrs
Dave Evans
Independent Director
$165K
55
1.1 yrs
Adam Hanft
Director
$285K
68
9.3 yrs
Jim McCann
Independent Director
$285K
67
5.3 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 06. Feb 19 | Sell | Katherine Littlefield | Individual | 04. Feb 19 | 04. Feb 19 | -2,665 | $74.07 | $-197,397 | ||
| 16. Jan 19 | Sell | Hagedorn Partnership LP | Company | 14. Jan 19 | 14. Jan 19 | -50,000 | $68.50 | $-3,413,477 | ||
| 18. Sep 18 | Sell | Nancy Mistretta | Individual | 14. Sep 18 | 14. Sep 18 | -6,300 | $76.93 | $-484,672 | ||
Management checks
We assess Scotts Miracle-Gro's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Scotts Miracle-Gro has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
SMG News
Simply Wall St News
Are The Scotts Miracle-Gro Company’s (NYSE:SMG) High Returns Really That Great?
The formula for calculating the return on capital employed is: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Scotts Miracle-Gro: 0.14 = US$394m ÷ (US$4.0b - US$1.2b) (Based on the trailing twelve months to March 2019.) So, Scotts Miracle-Gro has an ROCE of 14%. … How Scotts Miracle-Gro's Current Liabilities Impact Its ROCE Current liabilities are short term bills and invoices that need to be paid in 12 months or less. … The ROCE equation subtracts current liabilities from capital employed, so a company with a lot of current liabilities appears to have less capital employed, and a higher ROCE than otherwise.
Simply Wall St - – Full articleIs The Scotts Miracle-Gro Company's (NYSE:SMG) 50% ROE Better Than Average?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. … Our data shows Scotts Miracle-Gro has a return on equity of 50% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleWhat Is The Scotts Miracle-Gro Company's (NYSE:SMG) Share Price Doing?
saw a significant share price rise of over 20% in the past couple of months on the NYSE. … With many analysts covering the mid-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price? … However, could the stock still be trading at a relatively cheap price.
Simply Wall St - – Full articleShould You Be Worried About Insider Transactions At The Scotts Miracle-Gro Company (NYSE:SMG)?
So before you buy or sell The Scotts Miracle-Gro Company (NYSE:SMG), you may well want to know whether insiders have been buying or selling. … The Last 12 Months Of Insider Transactions At Scotts Miracle-Gro. … All up, insiders sold more shares in Scotts Miracle-Gro than they bought, over the last year
Simply Wall St - – Full articleIs The Scotts Miracle-Gro Company's (NYSE:SMG) High P/E Ratio A Problem For Investors?
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). … We'll look at The Scotts Miracle-Gro Company's (NYSE:SMG) P/E ratio and reflect on what it tells us about the company's share price. … Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)
Simply Wall St - – Full articleDo Directors Own The Scotts Miracle-Gro Company (NYSE:SMG) Shares?
The big shareholder groups in The Scotts Miracle-Gro Company (NYSE:SMG) have power over the company. … Scotts Miracle-Gro is a pretty big company. … Check out our latest analysis for Scotts Miracle-Gro
Simply Wall St - – Full articleThe Scotts Miracle-Gro Share Price Has Gained 37% And Shareholders Are Hoping For More
But The Scotts Miracle-Gro Company (NYSE:SMG) has fallen short of that second goal, with a share price rise of 37% over five years, which is below the market return. … One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. … During five years of share price growth, Scotts Miracle-Gro actually saw its EPS drop 15% per year.
Simply Wall St - – Full articleAre The Scotts Miracle-Gro Company’s Returns On Capital Worth Investigating?
To be precise, we'll consider its Return On Capital Employed (ROCE), as that will inform our view of the quality of the business. … Return On Capital Employed (ROCE): What is it? … ROCE measures the 'return' (pre-tax profit) a company generates from capital employed in its business.
Simply Wall St - – Full articleIs The Scotts Miracle-Gro Company's (NYSE:SMG) 35% Better Than Average?
By way of learning-by-doing, we'll look at ROE to gain a better understanding of The Scotts Miracle-Gro Company (NYSE:SMG). … Another way to think of that is that for every $1 worth of equity in the company, it was able to earn $0.35. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleWhat Did The Scotts Miracle-Gro Company's (NYSE:SMG) CEO Take Home Last Year?
This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. … How Does Jim Hagedorn's Compensation Compare With Similar Sized Companies. … According to our data, The Scotts Miracle-Gro Company has a market capitalization of US$3.5b, and pays its CEO total annual compensation worth US$5.2m.
Simply Wall St - – Full articleSMG Company Info
Description
The Scotts Miracle-Gro Company manufactures, markets, and sells consumer lawn and garden products in the United States and internationally. The company operates through three segments: U.S. Consumer, Hawthorne, and Other. It offers lawn care products, such as lawn fertilizers, grass seed products, spreaders, other durable products, and outdoor cleaners, as well as lawn-related weed, pest, and disease control products. The company also provides gardening and landscape products, including water-soluble and continuous-release plant foods, potting mixes and garden soils, mulch and decorative groundcover products, plant-related pest and disease control products, organic garden products, and lives goods and seeding solutions. In addition, it offers hydroponic products that help users grow plants, flowers, and vegetables in an indoor or urban environment; and insect control products, rodent control products, and weed control products for home areas. The company offers its products under the Scotts, Turf Builder, EZ Seed, PatchMaster, Thick’R Lawn, GrubEx, EdgeGuard, Handy Green II, Scotts OxiCleanTM3, Miracle-Gro, LiquaFeed, Osmocote, Shake ‘N Feed, Hyponex, Earthgro, SuperSoil, Fafard, Nature Scapes, Ortho, Miracle-Gro Organic Choice, Nature’s Care, Whitney Farms, EcoScraps, Gro-ables, Hydroponics, Gavita, Botanicare, Vermicrop, Agrolux, Can-Filters, Sun System, Gro Pro, Mother Earth, Hurricane, Grower's Edge, AeroGarden, Ortho Weed B Gon, Roundup, and Groundclear brands. It serves home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers, e-commerce platforms, food and drug stores, and indoor gardening and hydroponic distributors and retailers through a direct sales force, and network of brokers and distributors. The Scotts Miracle-Gro Company was founded in 1868 and is headquartered in Marysville, Ohio.
Details
| Name: | The Scotts Miracle-Gro Company |
| SMG | |
| Exchange: | NYSE |
| Founded: | 1868 |
| $4,872,613,485 | |
| 55,471,465 | |
| Website: | http://www.scotts.com |
| Address: |
The Scotts Miracle-Gro Company 14111 Scottslawn Road, Marysville, Ohio, 43041, United States |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NYSE | SMG | Common Shares | New York Stock Exchange | US | USD | 31. Jan 1992 | |
| DB | SCQA | Common Shares | Deutsche Boerse AG | DE | EUR | 31. Jan 1992 | |
| LSE | 0L45 | Common Shares | London Stock Exchange | GB | USD | 31. Jan 1992 |
Number of employees
Current staff
Industry
| Fertilizers and Agricultural Chemicals | |
| Materials |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/05/20 01:41 |
| End of day share price update: | 2019/05/17 00:00 |
| Last estimates confirmation: | 2019/05/02 |
| Last earnings filing: | 2019/05/08 |
| Last earnings reported: | 2019/03/30 |
| Last annual earnings reported: | 2018/09/30 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
